Author:
Yamamoto Katsuya,Kurata Keiji,Higashime Ako,Sai Satoshi,Yakushijin Kimikazu,Kawamoto Shinichiro,Kajimoto Kazuyoshi,Hayashi Yoshitake,Matsuoka Hiroshi,Minami Hironobu
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Leoncini L, Campo E, Stein H, et al. Burkitt-like lymphoma with 11q aberration. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumors of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC; 2017. p. 334.
2. Pienkowska-Grela B, Rymkiewicz G, Grygalewicz B, Woroniecka R, Krawczyk P, Czyz-Domanska K, et al. Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement. Med Oncol. 2011;28:1589–95.
3. Salaverria I, Martin-Guerrero I, Wagener R, Kreuz M, Kohler CW, Richter J, et al. A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B cell lymphomas resembling Burkitt lymphoma. Blood. 2014;123:1187–98.
4. Ferreiro JF, Morscio J, Dierickx D, Marcelis L, Verhoef G, Vandenberghe P, et al. Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain/loss pattern. Haematologica. 2015;100:e275–9.
5. Havelange V, Ameye G, Théate I, Callet-Bauchu E, Lippert E, Luquet I, et al. The peculiar 11q-gain/loss aberration reported in a subset of MYC-negative high-grade B cell lymphomas can also occur in a MYC-rearranged lymphoma. Cancer Genet. 2016;209:117–8.